Workflow
505(b)(2)监管途径
icon
搜索文档
Lipella Pharmaceuticals (NasdaqCM:LIPO) 2025 Conference Transcript
2025-09-19 01:32
Lipella Pharmaceuticals (NasdaqCM:LIPO) 2025 Conference September 18, 2025 12:30 PM ET Company ParticipantsMichael Chancellor - Chief Medical Officer & DirectorJonathan Kaufman - CEO & DirectorNoneHello, welcome to Virtual Investor Conferences. On behalf of OTC Markets, we're very pleased you're joining us for the Life Sciences Investor Forum. Our next presentation of the day is from Lipella Pharmaceuticals Inc. Please note, you may submit questions for the presenters in the box to the left of the slides, a ...